Serious but Rare Risks GLP-1 medications can aggravate or trigger severe pancreatic inflammation in some patients. Both oral and injectable GLP-1 medications may cause gallbladder disease, and in rare cases involving patients with relevant risk factors, there have been associations with thyroid changes observed in animal studies. A serious allergic reaction is possible but uncommon
The receptor question, in one paragraph The primary pharmacological differences between these peptides arise from the receptor they activate, although molecular structure and pharmacokinetic properties also contribute
The same precision that governs peptide synthesis at Real Peptides
Cancer Prevention and Nerve Regeneration Perhaps the most critical uses of all, GHK-CU is showing promising benefits for anti-tumor and cancer prevention, as well as nerve regeneration
Tell your doctor if you have or have had any medical conditions, including: a disease of the spinal cord or folate-deficient megaloblastic anaemia (a type of anaemia caused by the deficiency of another vitamin called folic acid)